We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
-16.14%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$518M
AUM Growth
-$140M
Cap. Flow
-$19.5M
Cap. Flow %
-3.75%
Top 10 Hldgs %
29.15%
Holding
139
New
12
Increased
23
Reduced
67
Closed
18

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.57M
2
BIIB icon
Biogen
BIIB
+$2.8M
3
NXPI icon
NXP Semiconductors
NXPI
+$1.95M
4
MSFT icon
Microsoft
MSFT
+$1.02M
5
CVX icon
Chevron
CVX
+$971K

Sector Composition

Rank Sector Weight
1 Technology 22.36%
2 Healthcare 20.28%
3 Industrials 13.56%
4 Consumer Discretionary 11.55%
5 Communication Services 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
51
FedEx
FDX
$72.7B
$4.08M 0.79%
33,670
-1,548
-4% -$218K
EA icon
52
Electronic Arts
EA
$53B
$4.04M 0.78%
40,337
-7,616
-16% -$801K
CMI icon
53
Cummins
CMI
$87.5B
$3.83M 0.74%
28,331
+1,518
+6% +$237K
CAT icon
54
Caterpillar
CAT
$375B
$3.8M 0.73%
32,782
-1,345
-4% -$172K
YUM icon
55
Yum! Brands
YUM
$41.8B
$3.76M 0.73%
54,899
+2,977
+6% +$278K
ZBH icon
56
Zimmer Biomet
ZBH
$18.2B
$3.63M 0.7%
36,952
-963
-3% -$126K
NVDA icon
57
NVIDIA
NVDA
$4.86T
$3.5M 0.67%
530,560
-40,400
-7% -$255K
BAX icon
58
Baxter International
BAX
$13.5B
$3.5M 0.67%
43,056
-715
-2% -$61.7K
CVX icon
59
Chevron
CVX
$392B
$3.43M 0.66%
47,338
-9,826
-17% -$971K
LH icon
60
Labcorp
LH
$25B
$3.4M 0.66%
31,341
-2,342
-7% -$337K
GSK icon
61
GSK
GSK
$104B
$3.38M 0.65%
71,490
-2,885
-4% -$154K
AXP icon
62
American Express
AXP
$227B
$3.35M 0.65%
39,123
-630
-2% -$73.3K
BUD icon
63
AB InBev
BUD
$170B
$3.32M 0.64%
75,217
-740
-1% -$48.3K
MDT icon
64
Medtronic
MDT
$109B
$3.29M 0.64%
36,527
-2,433
-6% -$259K
MDLZ icon
65
Mondelez International
MDLZ
$79.5B
$3.27M 0.63%
65,358
+3,285
+5% +$178K
HUBB icon
66
Hubbell
HUBB
$25B
$2.97M 0.57%
25,869
-170
-0.7% -$22.9K
BRK.B icon
67
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.92M 0.56%
15,948
+65
+0.4% +$13.8K
REGN icon
68
Regeneron Pharmaceuticals
REGN
$78.5B
$2.91M 0.56%
+5,964
New +$2.46M
INTU icon
69
Intuit
INTU
$86.5B
$2.82M 0.54%
12,278
-1,110
-8% -$301K
DT
70
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$2.6M 0.5%
201,277
+45,585
+29% +$590K
KO icon
71
Coca-Cola
KO
$377B
$2.11M 0.41%
47,688
-295
-0.6% -$15.9K
SNA icon
72
Snap-on
SNA
$21.2B
$1.65M 0.32%
15,185
EMR icon
73
Emerson Electric
EMR
$83.9B
$1.58M 0.31%
33,164
+550
+2% +$36.2K
TGT icon
74
Target
TGT
$65.6B
$1.57M 0.3%
16,940
-116
-0.7% -$12.9K
WTS icon
75
Watts Water Technologies
WTS
$11.5B
$1.54M 0.3%
18,165
-910
-5% -$87.1K

Similar funds

Jacobs & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Jacobs & Co held 139 positions worth $518M, down 21% from $658M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Jacobs & Co withdrew a net $19.5M in Q1 2020, closing 18 positions and reducing 67 holdings. Its most notable exit was Biogen, an estimated $2.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Jacobs & Co opened a new position in Amazon worth $17.6M.

  • Jacobs & Co's largest Q1 2020 buy was Amazon: 180,920 shares worth $17.6M.
  • Jacobs & Co added most to DEUTSCHE TELEKOM AG ADS (1ORD) in Q1 2020, an estimated $590K increase.
  • Jacobs & Co's biggest Q1 2020 reduction was Apple, cutting an estimated $3.57M.
  • Jacobs & Co fully exited Biogen in Q1 2020, selling an estimated $2.8M.
  • Jacobs & Co's ten largest holdings make up 29% of its $518M portfolio in Q1 2020.
  • Jacobs & Co opened 12 new positions and closed 18 in Q1 2020.
  • Jacobs & Co's portfolio value fell 21% quarter-over-quarter to $518M.

Based on Jacobs & Co's 13F filing for Q1 2020, filed 13 Apr 2020.